Golden State Equity Partners Ishares Tr Genomics Immunology Transaction History

Golden State Equity Partners

  • $182 Million
  • Q3 2024

A detailed history of Golden State Equity Partners transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Golden State Equity Partners holds 206 shares of IDNA stock, worth $4,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares
206
Holding current value
$4,729
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
BUY
$22.86 - $25.49 $4,709 - $5,250
206 New
206 $5,000
Q1 2023

Jun 01, 2023
SELL
$22.48 - $27.9 $156,955 - $194,797
-6,982 Closed
0 $0
Q1 2022

May 18, 2022
BUY
$31.36 - $43.88 $218,955 - $306,370
6,982 New
6,982 $241,000
Q1 2022

May 16, 2022
SELL
$31.36 - $43.88 $201,017 - $281,270
-6,410 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$43.23 - $51.35 $26,240 - $31,169
607 Added 10.46%
6,410 $281,000
Q3 2021

Nov 15, 2021
BUY
$48.15 - $55.47 $15,841 - $18,249
329 Added 6.01%
5,803 $294,000
Q2 2021

Aug 12, 2021
BUY
$43.63 - $52.03 $238,830 - $284,812
5,474 New
5,474 $285,000

Others Institutions Holding IDNA

# of Institutions
59
Shares Held
1.68M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email